Zhao X, Cui X-Y, Chu Q-P, Chen B-Q, Wang X-M, Lin Z-B, Li X-J, Ku B-S, Zhang Y-H
Department of Pharmacology, School of Basic Medical Science, Peking University, Beijing, China.
J Neural Transm (Vienna). 2006 Oct;113(10):1395-402. doi: 10.1007/s00702-005-0422-1. Epub 2006 Feb 9.
In order to elucidate the mechanism(s) behind the interactions between barbiturates and Ca(2+) antagonists, the effects of three structurally diverse types of Ca(2+) antagonists combined or not with 5-HT on pentobarbital-induced hypnosis in mice were investigated. The results showed that dihydropyridine derivative nifedipine (10.0 and 20.0 mg/kg, p.o.) and other types of Ca(2+) antagonist, verapamil (5.0 and 10.0 mg/kg, p.o.) and diltiazem (2.5, 5.0 and 10.0 mg/kg, p.o.) increased both the sleeping time in hypnotic dosage of pentobarbital (45 mg/kg, i.p.) treated mice and the rate of sleep onset in the sub-hypnotic dosage of pentobarbital (28 mg/kg, i.p.) treated mice in a dose-dependent manner, respectively, and these effects were significantly augmented by 5-hydroxytryptophan (5-HTP), the immediate precursor of 5-hydroxytryptamine (5-HT). Pretreatment with p-chlorophenylalanine (PCPA, 300 mg/kg, s.c.), an inhibitor of tryptophan hydroxylase, significantly decreased pentobarbital-induced sleeping time and nifedipine (10.0 mg/kg, p.o.), verapamil (5.0 mg/kg, p.o.) and diltiazem (2.5 mg/kg, p.o.) abolished this effect. From these results, it should be presumed that the augmentative effect of L-type Ca(2+) channel blockers on pentobarbital-induced sleep may be influenced by serotonergic system.
为阐明巴比妥类药物与钙拮抗剂之间相互作用的机制,研究了三种结构不同类型的钙拮抗剂单独或与5-羟色胺(5-HT)联合使用对小鼠戊巴比妥诱导催眠的影响。结果表明,二氢吡啶衍生物硝苯地平(10.0和20.0 mg/kg,口服)以及其他类型的钙拮抗剂维拉帕米(5.0和10.0 mg/kg,口服)和地尔硫䓬(2.5、5.0和10.0 mg/kg,口服)分别以剂量依赖的方式增加了戊巴比妥催眠剂量(45 mg/kg,腹腔注射)处理小鼠的睡眠时间以及戊巴比妥亚催眠剂量(28 mg/kg,腹腔注射)处理小鼠的睡眠起始率,并且5-羟色氨酸(5-HTP)(5-羟色胺(5-HT)的直接前体)显著增强了这些作用。用色氨酸羟化酶抑制剂对氯苯丙氨酸(PCPA,300 mg/kg,皮下注射)预处理可显著缩短戊巴比妥诱导的睡眠时间,而硝苯地平(10.0 mg/kg,口服)、维拉帕米(5.0 mg/kg,口服)和地尔硫䓬(2.5 mg/kg,口服)可消除这种作用。从这些结果推测,L型钙通道阻滞剂对戊巴比妥诱导睡眠的增强作用可能受5-羟色胺能系统影响。